anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

234,121-234,150 of 319,975

filter-aware
60
Slide 60 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
61
Part of a larger clinical pipeline presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
62
Part of a clinical pipeline appendix.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
63
Part of a larger clinical pipeline deck; includes navigation sidebar for therapeutic areas.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
64
Slide 64 from a corporate presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
65
Slide 65 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
66
Slide 66 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
67
Slide 67 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
68
Part of an appendix detailing clinical pipeline assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
69
Part of a series of slides detailing clinical pipeline assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
70
Slide 70 of a larger deck, likely part of an appendix detailing clinical pipeline assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
71
Slide 71 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
72
The slide provides a structured overview of a single clinical trial (NCT05877599) including population, design, endpoints, and status.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
73
The slide uses a table format to summarize trial design, patient count, endpoints, and status for a specific clinical trial.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
74
The slide is part of an appendix, specifically detailing early development oncology assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
75
AstraZeneca | Results Presentation Deck | 157 slidesAstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
76
Slide 76 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
77
Slide 77 from a corporate presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
78
The slide provides a structured overview of three specific clinical trials (Balanced-HF, MIRACLE, MIRO-CKD).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
79
The slide is part of an appendix, indicated by the page number 79 and the 'Appendix' label at the bottom.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
80
The slide is part of an appendix, specifically detailing clinical trial data.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
81
Slide 81 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
82
The slide uses a vertical navigation bar on the right to indicate the therapeutic area (CVRM) and development stage (Late-stage development).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
83
The slide provides a structured summary of the ZEAL trial design, including population, arms, endpoints, and status.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
84
The slide uses a vertical tab structure on the right to categorize therapeutic areas, with 'R&I' highlighted.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
85
The slide uses a vertical tab structure on the right to categorize therapeutic areas, with 'R&I' highlighted.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
86
The slide is part of an appendix, indicated by the footer and the R&I tab selection.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
87
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
88
The slide provides a structured overview of clinical trial progress for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
89
Slide 89 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit